努力提高我国心脏再同步治疗的应用水平

心脏再同步治疗（CRT）已成为伴QRS波增宽的慢性心力衰竭患者的有效治疗方法。多中心临床研究证实，CRT不仅能改善慢性心力衰竭伴心脏收缩不同步患者的心功能，提高生活质量，而且可以降低死亡率，改善患者预后。2002年ACC／AHA／NASPE第一次将CRT治疗心力衰竭列入起搏适应证（Ⅱa类）。随着循证医学证据的不断积累，CRT治疗心力衰竭的地位不断提升。

To improve cardiac resynchronization therapy in China

Cardiac resynchronization therapy(CRT) has proven to be an effective adjunctive therapy to pharmacologic management in reducing the rate of hospitalization in symptomatic patients with advanced heart-failure,an ejection fraction of 0. 35 or less,and an intraventricular conduction delay of 120 ms or more. In this issue of the Journal, seven papers related to the home monitoring, the appropriate treatment of phrenic nerve stimulation, the predictors of response to CRT, and the surgical implantation of left ventricular epicardial electrode were published. Although there were some shortcoming in those papers, new ideas or information were provided. Despite substantial advances in treatment of heart failure, biggap still have exists in the management of heart failure using CRT between developed countries and china. We should strive to make progress in the diagnoses and treatment of heart failure using CRT.